CD8A and COVID-19: Furthermore, the inhibitory membrane receptors expressed by CD8+ T cells, such as PDCD1 (PD1), CTLA4, and HAVCR2 (TIM3), were significantly upregulated in severe COVID-19 patients when compared with those in healthy people and mild COVID-19 patients (Figure 5F).